2020
PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma
Haider SP, Mahajan A, Zeevi T, Baumeister P, Reichel C, Sharaf K, Forghani R, Kucukkaya AS, Kann BH, Judson BL, Prasad ML, Burtness B, Payabvash S. PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma. European Journal Of Nuclear Medicine And Molecular Imaging 2020, 47: 2978-2991. PMID: 32399621, DOI: 10.1007/s00259-020-04839-2.Peer-Reviewed Original ResearchConceptsOropharyngeal squamous cell carcinomaMetastatic cervical lymph nodesCervical lymph nodesLymph nodesSquamous cell carcinomaPrimary tumorPET/CTHPV associationCell carcinomaRadiomics signatureVolume of interestHuman papilloma virus associationHuman papillomavirus associationMulti-national cohortNon-contrast CTHPV statusFDG-PETExternal cohortVirus associationFinal modelTumorsRadiomic featuresCTSignificant differencesLesion features
2013
Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes.
Marrone K, Otremba M, Groisberg R, Deshpande H, Crawford F, Acevedo-Gadea C, Gould Rothberg BE, Judson B, Morgensztern D. Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes. Journal Of Clinical Oncology 2013, 31: 6076-6076. DOI: 10.1200/jco.2013.31.15_suppl.6076.Peer-Reviewed Original ResearchSquamous cell carcinomaStage IVAOverall survivalCell carcinomaOral cavityStage IVA squamous cell carcinomaIVA squamous cell carcinomaPatients meeting inclusion criteriaProportional hazards regression modelsLymph node categoryEnd Results (SEER) databaseLymph node statusKaplan-Meier methodLog-rank testHazards regression modelsMost clinical trialsCombination of tumorSubtypes of patientsMeeting inclusion criteriaSignificant differencesMost patientsIndependent predictorsNode statusResults databaseStage subgroups